Distribution of two VIP-related peptides, helospectin and pituitary adenylate cyclase activating peptide (PACAP), in the human upper respiratory system

Regulatory Peptides

Volumn 65, Issue 3, 1996, Pages 203-209

  Hauser Kronberger, Cornelia ^a   Hacker, Gerhard W ^a   Albegger, Klaus ^a   Muss, Wolfgang H ^a   Sundler, Frank ^b   Arimura, Akira ^c   Dietze, Otto ^a  

^a St Johanns Spital   (Austria)

^b LUND UNIVERSITY   (Sweden)

^c TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Immunocytochemistry; Larynx; Nasal mucosa; Soft palate; Tongue

Indexed keywords

HELOSPECTIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LARYNX; NORMAL HUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SOFT PALATE; TONGUE; UPPER RESPIRATORY TRACT;

HELODERMA HORRIDUM; OVIS; SQUAMATA;

EID: 0030590416     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-0115(96)00100-0     Document Type: Article

References (35)

1. [1] Absood, A., Ekblad, E., Ekelund, M., Hakanson, R. and Sundler, F., Helospectin-like peptides in the gastrointestinal tract: immunocytochemical localization and immunochemical characterization, Neuroscience, 46 (1990) 432-438.
2. [2] Desai, H., Uddman, R., Malina, J. and Sundler, F., Helospectin-like immunoreactivity in the esophagus, Regul. Pept., 40 (1992) 363-371.
3. [3] Shen, Z., Larsson, L.T., Malmfors, G., Absood, A., Hakanson, R. and Sundler, F., A novel neuropeptide, pituitary adenylate cyclase-activating polypeptide (PACAP), in human intestine: evidence for reduced content in Hirschsprung's disease, Cell Tissue Res., 269 (1992) 369-374.
4. [4] Uddman, R., Luts, A., Absood, A., Arimura, A., Ekelund, M., Desai, H., Hakanson, R., Hambreaus, G. and Sundler, F., PACAP, a VIP-like peptide, in neurons of the esophagus, Regul. Pept., 36 (1991) 415-422.
5. [5] Sundler, F., Ekblad, E., Absood, A., Hakanson, R., Koves, K. and Arimura, A., Pituitary adenylate cyclase activating peptide in the gut, Neuroscience, 46 (1992) 439-454.
6. [6] Kivipelto, L., Absood A., Arimura A., Sundler F., Hakanson R. and Panula P., The distribution of pituitary adenylate cyclase-activating polypeptide-like immunoreactivity is distinct from helodermin- and helospectin-like immunoreactivities in the rat brain. J. Chem. Neuroanat., 5 (1992) 85-94.
7. [7] Luts, A., Uddman, R., Alm, P., Basterra, J. and Sundler, F., Peptide-containing nerve fibers in human airways: distribution and coexistence pattern. Int. Arch. Allergy Immunol., 101 (1993) 52-60.
8. [8] Moller, K., Zhang, Y-Z., Hakanson, R., Luts, A., Sjölund, B., Uddman, R. and Sundler, F., Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience, 57 (1993) 725-732.
9. [9] Graf, A.-H., Schiechl, A., Hacker, G.W., Hauser-Kronberger, C., Steiner, H., Arimura, A., Sundler, F., Staudach, A. and Dietze, O., Helospectin and pituitary adenylate cyclase activating polypeptide in the human vagina, Regul. Pept., 55 (1995) 277-286.
10. [10] Arimura, A., Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research, Regul. Pept., 37 (1992) 287-303.
11. [11] Ahren, B. and Falck, B., Effects of helodermin and VIP on insulin and glucagon secretion in the mouse, Regul. Pept., 32 (1991) 1-91.
12. [12] Miyata, A., Arimura, A., Dahl, R.R, Minamino, N., Uehara, A., Jiang, L., Culler, M.D. and Coy, D.H., Isolation of a novel 38 residue-hypothalamic peptide which stimulates adenylate cyclase in pituitary cells, Biochem. Biophys. Res. Commun., 164 (1989) 567-574.
13. [13] Miyata, A., Jiang, L., Dahl, RD, Kitada, C., Kubo, K., Fujino L., Minamino N. and Arimura A., Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP-38), Biochem. Biophys. Res. Commun., 170 (1990) 643-648.
14. [14] Warren, J.B., Donnelley, L.E. and Cullen, S., Pituitary adenylate cyclase activating polypeptide: a novel, long lasting, endothelium-independent vasorelaxant, Eur. J. Pharmacol., 197 (1991) 131-134.
15. [15] Grundemar, L. and Högestatt, E.D., Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP), Br. J. Pharmacol., 99 (1990) 526-528.
16. [16] Absood, A., Chen, D., Wang, Z.Y. and Hakanson, R., Vascular effects of pituitary adenylate cyclase activating peptide: a comparison with vasoactive intestinal peptide, Regul. Pept., 40 (1992) 323-329.
17. [17] Raufman, J-P., Jensen, R.T., Sutcliff, V.E., Pisano, J.J. and Gardner, J.D., Actions of Gila monster venom on dispersed acini from guinea pig pancreas, Am. J. Physiol., 242 (1982) G470-G474.
18. [18] Mungan, Z., Ozmen, V., Ertan, A. and Arimura, A., Pituitary adenylate cyclase activating polypeptide-27 (PACAP-27) inhibits pentagastrin stimulated gastric acid secretion in conscious rats, Regul. Pept., 38 (1992) 199-206.
19. +-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide, Res. Commun. Chem. Pathol. Pharmacol., 79 (1993) 11-22.
20. [20] Zhang, Y.-Z., Sjölund, B., Moller, K., Hakanson, R. and Sundler, F., Pituitary adenylate cyclase activating peptide produces a marked and longlasting depression of a C-fibre-evoked flexion reflex. Neuroscience, 57 (1993) 733-737.
21. [21] Kimura, C., Ohkubo, S. and Ogi, K., A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNA's. Biochem. Biophys. Res. Commun., 166 (1990) 81-89.
22. [22] Lam, H-C., Takahashi, K., Ghatei, M.A. Kanse, S.M., Polak, J.M. and Bloom, S.R., Binding sites of a novel neuropeptide pituitary adenylate cyclase activating poly peptide in the rat brain and lung, Eur. J. Biochem., 193 (1990) 725-729.
23. [23] Gottschall, P.E., Tatsuno, I., Miyata, A. and Arimura, A., Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase activating polypeptide, Endocrinology, 127 (1990) 272-277.
24. [24] Buscail, L., Gourlet, P. and Cuavin, A., Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR4-2J, FEBS Lett., 262 (1990) 77-81.
25. [25] Arimura A., Receptors for pituitary adenylate cyclase-activating polypeptide. Comparison with vasoactive intestinal peptide receptors. Trends Endocrinol. Metab., 3 (1992) 288-294.
26. [26] Arimura A. and Shioda S., Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: Neuroendocrine and endocrine interaction, Front. Neuroendocrinol., 16 (1995) 53-88.
27. [27] Nandha, K.A., Benito-Orfila, M.A., Smith, D.M., Ghatei, M.A. and Bloom, S.R., Action of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on the rat vascular system: effects on blood pressure and receptor binding, J. Endocrinol., 129 (1991) 69-73.
28. [28] Hauser-Kronberger, CE., Hacker, GW., Sundler, F., Thurner, J. and Albegger, K., Distribution and co-localization of immunoreactive helospectin with vasoactive intestinal polypeptide and peptide histidine methionine in human nasal mucosa, soft palate and larynx. Eur. Arch. Otorhinolaryngol., 249 (1992) 201-205.
29. [29] Kummer W., Hauser-Kronberger C. and Muss W., Pre-embedding immunocytochemistry in transmission electron microscopy. In J. Gu and G.W. Hacker (Eds.), Modern Methods in analytical Morphology, Plenum Press, New York, 1994, pp. 187-201.
30. [30] Koves, K., Arimura, A., Grocs, T.G. and Somogyvari-Vigh, A., Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain, Neuroendocrinology, 54 (1991) 159-169.
31. [31] Ichimura, K., Mineda, H. and Seki, A., Vascular effects of neuropeptides on nasal mucosa, Ann. Otol. Rhinol. Laryngol., 97 (1988) 289-293.
32. [32] Lundberg, J.M., Martling, C.-R. and Hökfelt, T., Airways, oral cavity and salivary glands: classical transmitters and peptides in sensory and autonomic motor neurons, In: A. Björklund, T. Hökfelt and C. Owman (Eds.), Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam, pp. 391-444.
33. [33] Kurian, S.S., Blank, M.A. and Sheppard, M.N., Vasoactive intestinal polypeptide in vasomotor rhinitis, Clin. Biochem., 11 (1983) 425-428.
34. [34] Moody, T.W., Zia, F. and Makheja, A., Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells, Peptides, 14 (1993) 241-246.
35. [35] Shivers, B.D., Göres, T.J., Gottschall, P.E. and Arimura, A., Two high affinity binding sites for pituitary adenylate cyclase activating polypeptide have different tissue distribution, Endocrinology, 128 (1991) 3055-3065.